Myocardial Pathology in COVID-19-Associated Cardiac Injury: A Systematic Review

Aniello Maiese1,2, Paola Frati2,3, Fabio Del Duca3

  • 1Department of Surgical Pathology, Medical, Molecular and Critical Area, Institute of Legal Medicine, University of Pisa, 56126 Pisa, Italy.

Insights

This review of COVID-19 autopsies reveals SARS-CoV-2 causes heart damage, including inflammation and microthrombosis. Survivors face increased cardiac risk due to these irreversible changes.

Area of Science:

  • Pathology
  • Cardiology
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, can affect multiple organs due to widespread ACE2 receptor expression.
  • Cardiac involvement is a significant concern in COVID-19 patients, necessitating a deeper understanding of its pathological basis.
  • Postmortem analysis offers crucial insights into the direct effects of emerging infectious diseases on human organs.

Purpose of the Study:

  • To systematically review postmortem findings in SARS-CoV-2 positive patients, focusing on cardiac involvement.
  • To analyze pathological and immunohistochemical data to understand the mechanisms of COVID-19-related heart disease.
  • To assess the long-term cardiac implications for COVID-19 survivors based on autopsy findings.

Main Methods:

  • Systematic literature search from March 2020 to July 2021 in PubMed using terms: 'COVID-19', 'postmortem', 'autopsy', 'heart'.
  • Inclusion of 16 English-written papers (case reports/series, original research) adhering to PRISMA guidelines.
  • Analysis of pathological findings, immunohistochemical data, and clinical assessments from 209 SARS-CoV-2 positive patients.

Main Results:

  • The primary cause of death was respiratory failure, with acute heart failure being the second most common cause.
  • Key cardiac findings included dilatation, necrosis, lymphocytic infiltration, and microthrombosis in small coronary vessels.
  • Immunohistochemistry showed a systemic inflammatory response with CD3+, CD8+ cytotoxic lymphocytes, and CD68+ macrophages.

Conclusions:

  • SARS-CoV-2 infection can lead to irreversible cardiac damage, contributing to increased cardiac risk in survivors.
  • COVID-19 induces a systemic inflammatory and prothrombotic state, impacting multiple organs, including the heart.
  • Postmortem examinations are essential for understanding the pathology of novel diseases like COVID-19 and their organ-specific effects.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
71
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
82
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
47
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
127
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
84